The American Society of Clinical Oncology–University of yankee Pathologists (ASCO–CAP) pointers have continued to evolve to Enhance the accuracy and clinical utility of HER2 testing by offering certain algorithms15,sixteen. In parallel with current procedures, novel strategies to quantify HER2 amounts or standardize methods are now being investigated, such as quantitative https://www.directivepublications.org/journal-of-clinical-breast-cancer/